Choose eClinical Software Built for the Full Study Lifecycle, Not Just Startup

Selecting an RTSM partner often centers on one metric: how quickly they can get a study live. But as Ryan Keane explains in this interview, speed at startup is only one chapter in a much longer story — one that spans years of protocol adjustments, dosing changes, enrollment shifts, and operational surprises.

He explores why decisions made for short‑term convenience frequently create hidden complexity later, forcing teams into rework, rigid workflows, or system limitations that become apparent only once the trial is active. The conversation highlights a more strategic way to evaluate RTSM options: by assessing how well the technology and service model support the entire life of a study, not just its kickoff.

From flexibility and scalability to the ability to absorb mid‑trial changes without disruption, Keane outlines the questions sponsors should be asking long before a contract is signed. The result is a more thoughtful approach to vendor selection — one that prioritizes long‑term stability and operational resilience over quick wins.